Skip to content

What probiotic is recommended for IBS? A comprehensive guide to effective strains

4 min read

According to a 2023 meta-analysis of over 80 randomized controlled trials, specific probiotic strains, particularly Lactobacillus and Bifidobacterium, were more effective than placebos in improving overall IBS symptoms. This is a crucial finding for anyone wondering what probiotic is recommended for IBS management and symptom relief.

Quick Summary

Targeting IBS symptoms with probiotics requires a strain-specific approach. Different bacterial and yeast strains can help alleviate common IBS symptoms like bloating, abdominal pain, constipation, and diarrhea.

Key Points

  • Strain Specificity: The effectiveness of probiotics for IBS is dependent on the specific strain, not just the genus.

  • IBS-D Relief: Saccharomyces boulardii is a key probiotic yeast recommended for IBS with diarrhea, including cases triggered by infection.

  • IBS-C Support: Strains like Bifidobacterium lactis BB-12 and HN019 have been clinically shown to improve bowel regularity and transit time for IBS with constipation.

  • Bloating and Pain Reduction: Strains such as Bifidobacterium infantis 35624 and Bifidobacterium bifidum MIMBb75 are effective for general IBS symptom relief, including abdominal pain and bloating.

  • Combination Formulas: A multi-strain probiotic containing a mix of Lactobacillus and Bifidobacterium species can also be beneficial, but efficacy varies by combination.

  • Choosing a Supplement: Look for products with clinically studied strains, check CFU count and stability, and consider third-party tested and low FODMAP-certified options.

In This Article

Understanding the Importance of Strain Specificity

The gut microbiome is a complex ecosystem, and the effectiveness of probiotics in managing Irritable Bowel Syndrome (IBS) is highly dependent on the specific strain or combination of strains used. The vast number of probiotic products available, each with a unique profile, means that a 'one-size-fits-all' approach is ineffective for IBS relief. Research has identified several strains and combinations that show promise in alleviating specific symptoms associated with IBS, which can manifest as diarrhea-predominant (IBS-D), constipation-predominant (IBS-C), or mixed-type (IBS-M).

Targeting IBS with Diarrhea (IBS-D)

For individuals with IBS-D, the goal is often to normalize bowel function and reduce episodes of urgent diarrhea. Certain probiotic strains have been studied for their ability to combat this specific issue:

  • Saccharomyces boulardii (CNCM I-745): A beneficial yeast, S. boulardii has shown potential in managing and preventing diarrhea from various causes, including post-infectious IBS. As it is a transient probiotic, some recommend taking a companion probiotic with beneficial bacteria for long-term gut support.
  • Bacillus coagulans (MTCC 5856 or Unique IS2): Studies have found Bacillus coagulans to be among the most effective probiotics for improving abdominal pain in patients with IBS, including those with IBS-D.
  • Lactiplantibacillus plantarum (Lp299v): While often recognized for a broader range of IBS symptoms, research has shown this strain to be particularly beneficial for reducing gas and bloating in IBS patients, which can accompany IBS-D.

Addressing IBS with Constipation (IBS-C)

For those who experience constipation as a primary symptom, certain probiotic strains can help improve bowel motility and increase stool frequency:

  • Bifidobacterium lactis (BB-12): Extensively researched for IBS-C, studies indicate that this strain can significantly decrease intestinal transit time and normalize bowel movements in individuals with a tendency towards constipation.
  • Bifidobacterium lactis (HN019): Similar to BB-12, this strain has been shown to improve intestinal transit time and may be particularly helpful for IBS-C sufferers who are sensitive to prebiotics.
  • Bifidobacterium longum (BB536): This robust strain has been associated with improved bowel regularity and can contribute to a healthier overall gut environment for those with IBS-C.

Alleviating Bloating and Abdominal Pain

Bloating and abdominal pain are common and often distressing symptoms for many IBS patients, regardless of their subtype. Several strains have demonstrated efficacy in addressing these core issues:

  • Bifidobacterium infantis (35624): Also known as B. longum subsp. infantis 35624, this is a highly studied strain that has shown efficacy in reducing overall IBS symptoms, including pain and bloating.
  • Lactobacillus acidophilus (NCFM): Considered a versatile strain for general gut support, L. acidophilus NCFM has been shown to improve bloating in patients with functional bowel disorders.
  • Bifidobacterium bifidum (MIMBb75): This strain has been shown to significantly improve overall IBS symptoms, including abdominal pain and bloating. Research has also found it to be effective even in its heat-inactivated form, which offers improved stability.

Comparison of Key IBS-Targeted Probiotic Strains

Probiotic Strain Primary Benefit for IBS Targeted Symptoms Key Studies / Support
Saccharomyces boulardii IBS with Diarrhea (IBS-D) Diarrhea, post-infectious IBS Multiple studies support its use for diarrhea, including post-infectious IBS.
Bifidobacterium lactis BB-12 IBS with Constipation (IBS-C) Constipation, improved transit time Clinical trials show improved bowel movements and transit time.
Bifidobacterium infantis 35624 Overall IBS Symptoms Abdominal pain, bloating, discomfort Well-researched for general IBS symptom reduction.
Lactiplantibacillus plantarum Lp299v Bloating and Pain Abdominal pain, gas, flatulence Clinically trialed to reduce pain and flatulence.
Bifidobacterium bifidum MIMBb75 Overall IBS Symptoms Abdominal pain, bloating, composite score Demonstrated significant improvement in overall symptoms and pain.
Lactobacillus acidophilus NCFM Overall Gut Support, Bloating Bloating, abdominal discomfort Shown to help reduce bloating in functional bowel disorders.

Choosing the Right Probiotic for Your IBS

When selecting a probiotic supplement, it is crucial to consider several factors beyond just the brand name. The most effective approach is a targeted, symptom-based strategy:

  • Match the Strain to the Symptom: As highlighted above, different strains address different symptoms. Identify your predominant IBS type (D, C, or M) and select a product containing the strains that are clinically proven for those specific issues.
  • Look for Clinical Evidence: Prioritize products that contain strains supported by robust clinical trials. The strain designation (e.g., Lp299v, 35624) is key, as effects are strain-specific.
  • Consider Multi-Strain Formulas: While some single strains are effective, a combination of strains may also offer benefits. Formulas containing a mix of Lactobacillus and Bifidobacterium species have shown positive results in some meta-analyses.
  • Check CFU Count and Stability: The CFU (Colony Forming Unit) count indicates the number of live bacteria. While a higher CFU count isn't always better, a range of 10-20 billion is often recommended. Look for products that are shelf-stable or require refrigeration based on the specific strains, as viability is critical for efficacy.
  • Assess Low FODMAP Compatibility: For individuals following a low FODMAP diet, be aware that some fermented foods are high in FODMAPs. Certain supplements, like Seed DS-01, include non-fermenting prebiotics that are compatible with this diet.
  • Prioritize Third-Party Testing: Look for third-party certifications to ensure the product's purity and potency.

Conclusion: Personalizing Your Probiotic Approach

In conclusion, there is no single probiotic that is universally recommended for IBS. The best approach involves identifying your specific symptoms and selecting a probiotic strain or combination that has been clinically proven to target those issues. Promising candidates include Saccharomyces boulardii for IBS-D, Bifidobacterium lactis BB-12 for IBS-C, and Bifidobacterium infantis 35624 for general symptom relief, especially pain and bloating. However, a significant component of IBS management is personalized, so it is often a process of trial and error to find what works best for your unique gut. As with any supplement, it is always recommended to consult with a healthcare provider or a registered dietitian to ensure the product is appropriate for your needs. For further information, the National Institutes of Health provides extensive resources on probiotics for health.

Frequently Asked Questions

There is no single 'best' probiotic for everyone with IBS, as different strains target different symptoms. Research shows efficacy for strains like Bifidobacterium infantis 35624 for general symptoms, Saccharomyces boulardii for diarrhea, and Bifidobacterium lactis BB-12 for constipation.

First, identify your predominant IBS symptoms (e.g., diarrhea, constipation, bloating). Then, look for a product that contains a strain specifically studied and shown to be effective for those symptoms. Consulting a healthcare provider is also recommended.

While unlikely, some people may experience worsened symptoms, especially initially or with certain strains or foods. For example, some fermented foods are high in FODMAPs, which can trigger symptoms in sensitive individuals. If symptoms worsen, it is best to stop the supplement and consult a doctor.

Both single and multi-strain probiotics can be effective. Some research suggests certain multi-strain combinations, particularly those including Lactobacillus and Bifidobacterium, offer broader symptom improvement. However, some studies show single strains can be highly effective for specific outcomes.

The time frame for noticing effects varies among individuals and studies. Many clinical trials show results within 4 to 8 weeks, but consistency is key. If a probiotic is beneficial, it may need to be taken daily for sustained relief.

Probiotic-rich fermented foods like yogurt, kimchi, and sauerkraut can be beneficial. However, some contain high FODMAPs, which can aggravate IBS symptoms. Supplements offer a more controlled dose of specific strains without the FODMAP risk.

Check for the specific strain name (e.g., Saccharomyces boulardii CNCM I-745), a sufficient CFU count (often 10-20 billion), and indications of third-party testing for quality assurance.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.